Evidence map›Paper›PMID 31044343›Full record

ReviewCurrent pain and headache reports2019

Government Legislation in Response to the Opioid Epidemic.

Mark R Jones, Matthew B Novitch, Syena Sarrafpour, Ken P Ehrhardt, Benjamin B Scott, Vwaire Orhurhu, Omar Viswanath, Alan D Kaye, Jatinder Gill, Thomas T Simopoulos

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05037682 (Addressing Opioid Use Disorder in the Elderly Through Primary Care Innovation), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05037682 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Addressing Opioid Use Disorder in the Elderly Through Primary Care Innovation: Pain and Opioid Management in Older Adults

TypeinterventionalSponsorUniversity of OklahomaRan2020 to 2024Enrolled1,035ConditionsPain, Chronic, Opioid Use DisorderArmsDissemination and Implementation Research
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Xylazine: A Drug Adulterant of Clinical Concern.Current pain and headache reports · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mark R JonesDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA. mjones13@bidmc.harvard.edu.
Matthew B NovitchMedical College of Wisconsin, Wausau, WI, 54401, USA.
Syena SarrafpourDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA.
Ken P EhrhardtDepartment of Anesthesiology, Louisiana State University Health Science Center, New Orleans, LA, 70112, USA.
Benjamin B ScottDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Vwaire OrhurhuDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA.
Omar ViswanathValley Anesthesiology and Pain Consultants, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
Alan D KayeDepartment of Anesthesiology, Louisiana State University Health Science Center, New Orleans, LA, 70112, USA.
Jatinder GillDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA.
Thomas T SimopoulosDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewOpioid misuse and abuse in the USA has evolved into an epidemic of tragic pain and suffering, resulting in the estimated death of over 64,000 people in 2016. Governmental regulation has escalated alongside growing awareness of the epidemic's severity, both on the state and federal levels. RECENT

findingsThis article reviews the timeline of government interventions from the late 1990s to today, including the declaration of the opioid crisis as a national public health emergency and the resultant changes in funding and policy across myriad agencies. Aspects of the cultural climate that fuel the epidemic, and foundational change that may promote sustained success against it, are detailed within as well. As a consequence of misuse and abuse of opioids, governmental regulation has attempted to safeguard society, and clinicians should appreciate changes and expectations of prescribers.

Indexed as

Federal GovernmentState GovernmentAnalgesics, OpioidEpidemicsHumansOpioid-Related DisordersPrescription Drug MisuseAnalgesics, OpioidAbuse-deterrent formulationsAddictionCommission on combating drug addictionOpioid crisisOpioid epidemicOverdosePrescription drug monitoring program

Identifiers

PMID31044343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.